Global gonorrhea diagnostic market is expected to witness a significant growth during the forecast period owing to the growing prevalence of the disease worldwide and unmet need in the faster diagnosis tools. According to the U.S. Center for Disease Control and Prevention (CDC), prevalence rate of gonorrhea was around 106 per million per year in past few years.

1. Grand View Research
Market Research & Consulting
Gonorrhea Diagnostic Market Analysis, Size,
Share, Growth, Trends and Segment Forecasts
to 2022
Global gonorrhea diagnostic market is expected to witness a significant growth
during the forecast period owing to the growing prevalence of the disease
worldwide and unmet need in the faster diagnosis tools. According to the U.S.
Center for Disease Control and Prevention (CDC), prevalence rate of gonorrhea
was around 106 per million per year in past few years. According to the official
data presented by CDC, 333,004 cases of gonorrhea were registered in the U.S. in
2013. It is estimated by CDC that more than 820000 people in U.S. get gonococcal
infections each year, yet less than half get reported. In the UK around 28000 cases
are reported each year. Lack of awareness about the disease and uncertain
symptoms of the disease are the factors expected to aid in the growing
prevalence of the disease. Frequent introduction of technologically advanced
tools for the detection of the disease causing bacteria and to study lesions is the
factor continuing the growth of the market during forecast period. Additionally,
development of resistance in gonococcal bacteria owing to the growing number
of non-prescription and unlawful usage of antibiotics such as seftriaxone,
doxycyclin and azithromycine used in the management of the disease. Recent
reports by the WHO have stated about failure of third line drug cephalosporin in
the treatment of gonorrhea especially in the regions such as Japan, Australia and
Hong Kong.

2. Grand View Research
View summary of "Gonorrhea Diagnostic Market Analysis Report" @
http://www.grandviewresearch.com/industry-analysis/gonorrhea-diagnostic-
market
Based on the type of the diagnostic test, gonorrhea diagnostic market is
segmented into, flow cytometry, diagnostic imaging, gel micro-droplets, artificial
intelligence, chromatography, Differential light scattering (DLS), liposomes,
monoclonal antibodies, and molecular diagnostics tests. Owing to the advantages
associated with it such as ease of doing the procedure, high accuracy and cost for
the performance, molecular diagnosis is the most popular and widely used
diagnostic test. Monoclonal antibody techniques are used extensively to
differentiate between gonorrhea and other diseases with similar symptoms. Flow
cytometry has been gaining popularity as an excellent tool for faster diagnosis
especially in females, despite the fact that 80% of the infected females fail to
show symptoms of the disease. The modern techniques such as artificial
intelligence and diagnostic imaging are in the testing phases and expected to
dominate the market in the future. Newer technologies for faster and accurate
detection of infection are expected to take over the traditional methods for
diagnosis and change the market scenario in the future gonorrhea diagnostic
market.
Geographically, the gonorrhea diagnostic market is segmented into North
America, Europe, Asia Pacific, Latin America, and MEA. North America is currently
capturing the largest market share of the market owing to the well developed
healthcare infrastructure, and favorable government policies regarding the
diagnosis and treatment of the sexually transmitted diseases. High awareness
level about the disease and favorable reimbursement policies are the factors
expected to boost the market during the forecast period. Market growth in the
Asia Pacific region and Middle East is expected to be faster owing to the growing
prevalence of the disease in the region and number of unmet needs in effective
diagnosis and treatments of the market. Growing awareness about sexually
transmitted diseases and the available cure for the same is supposed to help

3. Grand View Research
newer diagnostic tools for gonorrhea over traditional method of detection.
Rapidly changing lifestyles and involvement of multiple sex partners is the factor
anticipated to boost the market in the future. Though weak healthcare structure
and low disposable incomes may hamper the market in many countries of the
region, the market growth rate is expected to stabilize owing to the growing
number of hospitals, commercial labs and newer diagnostic techniques with cost
saving and faster procedures.
Major players in the market are Abott Laboratories, F. Hoffmann-La Roche AG,
Tosoh Corporation, Siemens AG, bioMérieux, PerkinElmer, Inc., and Ortho Clinical
Diagnostics. FDA recently approved Meridian Bioscience developed new
molecular amplification test illuminogen HSV I and II in July 2015. Many other
companies such as Cigna have been developing faster and innovative diagnostic
techniques. Faster and accuracy are the factors expected to make healthcare
practitioners frequently upgrade the diagnostic tools and use latest techniques.
This is expected to help new entrants to dominate the market. The scope for new
entrants is expected to be tremendous owing to the development in technology
and growing numbers of points of care globally.
Request TOC of “Gonorrhea Diagnostic Market Analysis Report" visit -
http://www.grandviewresearch.com/industry-analysis/gonorrhea-diagnostic-
market/request-toc
About Grand View Research

4. Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business
decisions, the company offers market intelligence studies ensuring relevant and
fact-based research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research